• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌中β-连环蛋白、Axin家族及APC基因的免疫组织化学分析和突变分析

Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas.

作者信息

Ishizaki Yasuyo, Ikeda Satoshi, Fujimori Masahiko, Shimizu Yosuke, Kurihara Takeshi, Itamoto Toshiyuki, Kikuchi Akira, Okajima Masazumi, Asahara Toshimasa

机构信息

Department of Surgery, Division of Frontier Medical Science, Programs for Biomedical Research, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima 734-8551, Japan.

出版信息

Int J Oncol. 2004 May;24(5):1077-83.

PMID:15067328
Abstract

Several lines of evidence show that the development of hepatocellular carcinoma (HCC) requires an accumulation of genetic alterations. However, molecular mechanism in HCC carcinogenesis remains unsolved. A total of 89 HCC samples were analyzed in this study to determine how alterations in the Wnt signaling pathway associate with the carcinogenesis of HCC. beta-catenin immunohistochemistry showed positive nuclear staining in 24 (27.0%) of the 89 HCC samples, indicating the existence of alterations in the Wnt signaling pathway in those 24 HCC samples. Mutations in the beta-catenin, Axin1 and Axin2 genes were detected in 10 (41.7%), 13 (54.2%) and 9 (37.5%) of the 24 beta-catenin-positive samples, respectively, but no mutation was detected in the APC gene. In conclusion, in addition to mutations in the beta-catenin gene, mutations in the Axin1 and Axin2 genes may alter the Wnt signaling pathway, resulting in accumulation of beta-catenin.

摘要

多项证据表明,肝细胞癌(HCC)的发生需要基因改变的积累。然而,HCC致癌的分子机制仍未解决。本研究共分析了89例HCC样本,以确定Wnt信号通路的改变与HCC致癌作用之间的关联。β-连环蛋白免疫组化显示,89例HCC样本中有24例(27.0%)核染色呈阳性,表明这24例HCC样本中存在Wnt信号通路的改变。在24例β-连环蛋白阳性样本中,分别有10例(41.7%)、13例(54.2%)和9例(37.5%)检测到β-连环蛋白、Axin1和Axin2基因的突变,但未在APC基因中检测到突变。总之,除了β-连环蛋白基因的突变外,Axin1和Axin2基因的突变可能会改变Wnt信号通路,导致β-连环蛋白的积累。

相似文献

1
Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas.肝细胞癌中β-连环蛋白、Axin家族及APC基因的免疫组织化学分析和突变分析
Int J Oncol. 2004 May;24(5):1077-83.
2
Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas.肝细胞癌和肝母细胞瘤中β-连环蛋白、AXIN1和AXIN2的突变谱。
Oncogene. 2002 Jul 18;21(31):4863-71. doi: 10.1038/sj.onc.1205591.
3
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.肝细胞癌中的AXIN1突变,以及通过病毒介导的AXIN1转移对癌细胞生长的抑制作用。
Nat Genet. 2000 Mar;24(3):245-50. doi: 10.1038/73448.
4
Mutations of beta-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis.β-连环蛋白和AXIN I基因的突变是人类肝细胞癌发生过程中的晚期事件。
Liver Int. 2005 Feb;25(1):70-6. doi: 10.1111/j.1478-3231.2004.0995.x.
5
Genetic alterations of Wnt signaling pathway-associated genes in hepatocellular carcinoma.肝细胞癌中Wnt信号通路相关基因的遗传改变
J Gastroenterol Hepatol. 2008 Jan;23(1):110-8. doi: 10.1111/j.1440-1746.2007.05250.x.
6
P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia.良性肿瘤中的P53基因与Wnt信号传导:肝腺瘤中存在β-连环蛋白突变,而局灶性结节性增生中则无。
Hepatology. 2002 Oct;36(4 Pt 1):927-35. doi: 10.1053/jhep.2002.36126.
7
Abnormalities of the APC/beta-catenin pathway in endometrial cancer.子宫内膜癌中APC/β-连环蛋白信号通路的异常
Oncogene. 2002 Nov 14;21(52):7981-90. doi: 10.1038/sj.onc.1205924.
8
Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.卵巢子宫内膜样腺癌中β-连环蛋白失调的多种机制。
Cancer Res. 2001 Nov 15;61(22):8247-55.
9
Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas.人肝细胞癌中失活的Axin1和激活的β-连环蛋白突变的差异效应。
Oncogene. 2007 Feb 1;26(5):774-80. doi: 10.1038/sj.onc.1209824. Epub 2006 Sep 11.
10
Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.E-钙黏蛋白在肝细胞癌中的表达改变:与基因改变、β-连环蛋白表达及临床特征的相关性
Hepatology. 2002 Sep;36(3):692-701. doi: 10.1053/jhep.2002.35342.

引用本文的文献

1
SENP1: A perspective from immune cells to disease (Review).SENP1:从免疫细胞到疾病的视角(综述)。
Oncol Rep. 2025 Sep;54(3). doi: 10.3892/or.2025.8947. Epub 2025 Jul 19.
2
Aberrant WNT/CTNNB1 Signaling as a Therapeutic Target in Human Breast Cancer: Weighing the Evidence.异常的WNT/CTNNB1信号通路作为人类乳腺癌的治疗靶点:权衡证据
Front Cell Dev Biol. 2020 Jan 31;8:25. doi: 10.3389/fcell.2020.00025. eCollection 2020.
3
Tankyrases/β-catenin Signaling Pathway as an Anti-proliferation and Anti-metastatic Target in Hepatocarcinoma Cell Lines.
端锚聚合酶/β-连环蛋白信号通路作为肝癌细胞系中的抗增殖和抗转移靶点
J Cancer. 2020 Jan 1;11(2):432-440. doi: 10.7150/jca.30976. eCollection 2020.
4
Correlations between chromobox homolog 8 and key factors of epithelial-mesenchymal transition in hepatocellular carcinoma.染色体盒同源物8与肝细胞癌上皮-间质转化关键因子之间的相关性
Cancer Cell Int. 2019 Dec 17;19:340. doi: 10.1186/s12935-019-1063-z. eCollection 2019.
5
Systems Challenges of Hepatic Carcinomas: A Review.肝癌的系统挑战:综述
J Clin Exp Hepatol. 2019 Mar-Apr;9(2):233-244. doi: 10.1016/j.jceh.2018.05.002. Epub 2018 May 17.
6
Next-generation sequencing and personalized genomic medicine in hepatobiliary malignancies.下一代测序与肝胆恶性肿瘤的个性化基因组医学
Hepat Oncol. 2015 Oct;2(4):359-370. doi: 10.2217/hep.15.20. Epub 2015 Nov 11.
7
Road to stemness in hepatocellular carcinoma.肝癌干性的发生通路。
World J Gastroenterol. 2017 Oct 7;23(37):6750-6776. doi: 10.3748/wjg.v23.i37.6750.
8
A mouse model for embryonal tumors with multilayered rosettes uncovers the therapeutic potential of Sonic-hedgehog inhibitors.一种具有多层玫瑰花结的胚胎肿瘤小鼠模型揭示了 Sonic-hedgehog 抑制剂的治疗潜力。
Nat Med. 2017 Oct;23(10):1191-1202. doi: 10.1038/nm.4402. Epub 2017 Sep 11.
9
Serine peptidase inhibitor Kazal type 1 (SPINK1) as novel downstream effector of the cadherin-17/β-catenin axis in hepatocellular carcinoma.丝氨酸蛋白酶抑制剂 Kazal 型 1(SPINK1)作为肝癌中钙黏蛋白 17/β-连环蛋白轴的新型下游效应物。
Cell Oncol (Dordr). 2017 Oct;40(5):443-456. doi: 10.1007/s13402-017-0332-x. Epub 2017 Jun 19.
10
Atypical regulators of Wnt/β-catenin signaling as potential therapeutic targets in Hepatocellular Carcinoma.Wnt/β-连环蛋白信号通路的非典型调节因子作为肝细胞癌潜在的治疗靶点
Exp Biol Med (Maywood). 2017 Jun;242(11):1142-1149. doi: 10.1177/1535370217705865. Epub 2017 Apr 21.